Amy Reyes

A comprehensive systematic review and meta-analysis of 36 randomized clinical trials shows that using activity trackers produces some health benefit, but primarily when combined with coaching.

A systematic review and meta-analysis of observational studies assessing the association between plant-based dietary patterns and the risk of type 2 diabetes among adults, provides the strongest evidence to date that eating a plant-based diet does indeed lower the risk of type 2 diabetes.

Vitamin D supplementation may not protect the heart from major adverse cardiovascular events, myocardial infarction, stroke or cardiovascular disease mortality, finds a study published in JAMA Cardiology.

A high consumption of ultra-processed foods (i.e. almost any consumable food item, except fresh fruits and vegetables) is associated with an increased risk of cardiovascular disease and mortality, show two studies in BMJ.

Patients with type 2 diabetes and kidney disease who received the SGLT2 inhibitor canagliflozin, had a lower risk of kidney failure and cardiovascular events as compared to a placebo group, a new study shows.

Infants who are not breastfed, or infrequently breastfed, have an increased risk of becoming obese, shows a WHO study presented last week at the European Conference on Obesity (ECO) held in Glasgow.

Rheumatology patients seeking natural alternatives for pain relief are increasingly turning to cannabis. An industry survey shows that 80 percent of rheumatologists in Canada field questions from patients every week about cannabis use, but this puts physicians in a quandary.

In 2018, the American College of Cardiology and American Heart Association teamed up to update treatment guidelines for atherosclerotic cardiovascular disease. Learn more in this recap.

A British study finds that rituximab is "neither clinically or cost-effective" in a study of patients with primary Sjogren’s syndrome who were being treated for fatigue and oral dryness.

In this news roundup, we offer a snapshot of some interesting studies we featured that pose never-ending perplexing questions: When do I switch patients from methotrexate to a biologic? Why didn't my patient report having an adverse reaction? Does vitamin D really protect bones?